Showing results (51-60 of 115) with videos related to
Sort By:
Pageof 12
The Journal of Biological Chemistry|April 19, 2007
Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residueManoj K Pandey, Santosh K Sandur, Bokyung Sung, et al.Cancer Research|July 3, 2008
Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosisManoj K Pandey, Bokyung Sung, Ajaikumar B Kunnumakkara, et al.Journal of Medicinal Chemistry|January 12, 2016
Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer AgentsDaniel Plano, Deepkamal N Karelia, Manoj K Pandey, et al.Bioorganic & Medicinal Chemistry Letters|March 15, 2016
Design, synthesis, and anti-breast cancer evaluation of new triarylethylene analogs bearing short alkyl- and polar amino-/amido-ethyl chainsGurleen Kaur, Mohinder P Mahajan, Manoj K Pandey, et al.Cancer Research|March 15, 2008
Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signalingTingfang Yi, Zhengfang Yi, Sung-Gook Cho, et al.Molecular Cancer Therapeutics|January 19, 2008
Identification of a novel blocker of IkappaBalpha kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor-kappaBBokyung Sung, Manoj K Pandey, Yuki Nakajima, et al.Talanta|October 31, 2008
Application of octadecanethiol self-assembled monolayer to cholesterol biosensor based on surface plasmon resonance techniqueSunil K Arya, Pratima R Solanki, Ravindra P Singh, et al.Blood|August 4, 2007
Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathwayManoj K Pandey, Bokyung Sung, Kwang Seok Ahn, et al.Cancers|July 13, 2024
Discovering Potential in Non-Cancer Medications: A Promising Breakthrough for Multiple Myeloma PatientsOmar S Al-Odat, Emily Nelson, Tulin Budak-Alpdogan, et al.Biochemical Pharmacology|November 9, 2025
Saga of MCL1 inhibitors in multiple myelomaEmily Nelson, Sandesh P Telang, Tulin Budak-Alpdogan, et al.Pageof 12